{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:14:39Z","timestamp":1778512479539,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["HO-16-6446"],"award-info":[{"award-number":["HO-16-6446"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.arbres.2019.12.015","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T20:29:22Z","timestamp":1581539362000},"page":"13-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study"],"prefix":"10.1016","volume":"57","author":[{"given":"Marc","family":"Miravitlles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f2nica","family":"Monteagudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iryna","family":"Solntseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardino","family":"Alc\u00e1zar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2019.12.015_bib0180","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2147\/COPD.S163749","article-title":"Are blood eosinophils a prime-time biomarker for COPD management decisions?","volume":"13","author":"Tsiligianni","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2019.12.015_bib0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","article-title":"Blood eosinophils and inhaled corticosteroid\/long-acting \u03b2-2 agonist efficacy in COPD","volume":"71","author":"Pavord","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2019.12.015_bib0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2019.12.015_bib0195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease","volume":"192","author":"Siddiqui","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2019.12.015_bib0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2019.12.015_bib0205","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jaci.2018.04.010","article-title":"Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease","volume":"141","author":"Yun","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.arbres.2019.12.015_bib0210","doi-asserted-by":"crossref","first-page":"1700761","DOI":"10.1183\/13993003.00761-2017","article-title":"Blood eosinophil count and exacerbation risk in patients with COPD","volume":"50","author":"Kerkhof","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2019.12.015_bib0215","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood eosinophils and exacerbations in chronic obstructive pulmonary disease the Copenhagen general population study","volume":"193","author":"Vedel-Krogh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2019.12.015_bib0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15412555.2018.1441275","article-title":"Demographic and clinical characteristics of COPD patients at different blood eosinophil levels in the UK clinical practice research datalink","volume":"15","author":"Landis","year":"2018","journal-title":"COPD"},{"key":"10.1016\/j.arbres.2019.12.015_bib0225","doi-asserted-by":"crossref","first-page":"1701162","DOI":"10.1183\/13993003.01162-2017","article-title":"Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD","volume":"50","author":"Casanova","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2019.12.015_bib0230","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2147\/COPD.S129787","article-title":"Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD","volume":"12","author":"Zysman","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2019.12.015_bib0235","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","article-title":"Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort","volume":"5","author":"Hastie","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2019.12.015_bib0240","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.medcli.2012.01.020","article-title":"SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research","volume":"138","author":"Bol\u00edbar","year":"2012","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.arbres.2019.12.015_bib0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.rmed.2015.12.004","article-title":"Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study","volume":"111","author":"Barrecheguren","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2019.12.015_bib0250","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2147\/COPD.S131016","article-title":"Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study","volume":"12","author":"Monteagudo","year":"2017","journal-title":"Int J Chron Obst Pulm Dis"},{"key":"10.1016\/j.arbres.2019.12.015_bib0255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6947-12-38","article-title":"Developing an algorithm to identify people with Chronic Obstructive Pulmonary Disease (COPD) using administrative data","volume":"12","author":"Smidth","year":"2012","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.arbres.2019.12.015_bib0260","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","article-title":"Eosinophils in COPD: just another biomarker?","volume":"5","author":"Bafadhel","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2019.12.015_bib0265","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02165-2017","article-title":"Peripheral eosinophil count as a biomarker for the management of COPD: not there yet","volume":"50","author":"Rabe","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2019.12.015_bib0270","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.arbres.2017.10.007","article-title":"CHACOS study group accuracy of a new algorithm to identify asthma-COPD overlap (ACO) patients in a cohort of patients with chronic obstructive airway disease","volume":"54","author":"P\u00e9rez de Llano","year":"2018","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2019.12.015_bib0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.rmed.2018.03.016","article-title":"Blood eosinophil levels as a biomarker in COPD","volume":"138","author":"Brusselle","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2019.12.015_bib0280","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.arbres.2017.04.002","article-title":"Consensus on the asthma-COPD overlap syndrome (ACOS) between the Spanish COPD guidelines (GesEPOC) and the Spanish guidelines on the management of asthma (GEMA)","volume":"53","author":"Plaza","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2019.12.015_bib0285","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.arbres.2018.03.021","article-title":"Characteristics of COPD patients managed in respiratory medicine departments in Spain according to GOLD groups and GesEPOC clinical phenotypes","volume":"54","author":"Izquierdo","year":"2018","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2019.12.015_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15412555.2019.1575802","article-title":"Practical guide to the identification and diagnosis of asthma-COPD overlap (ACO)","volume":"16","author":"Nu\u00f1ez","year":"2019","journal-title":"COPD"},{"key":"10.1016\/j.arbres.2019.12.015_bib0295","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1164\/rccm.201708-1684LE","article-title":"Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease","volume":"197","author":"Turato","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2019.12.015_bib0300","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12931-018-0840-x","article-title":"Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease","volume":"19","author":"Shin","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2019.12.015_bib0305","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.2147\/COPD.S170995","article-title":"Burden of disease associated with a COPD eosinophilic phenotype","volume":"13","author":"Ortega","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2019.12.015_bib0310","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00022-2018","article-title":"Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study","volume":"4","author":"Adir","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.arbres.2019.12.015_bib0315","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.201602-0353OC","article-title":"Asthma-like features and clinical course of chronic obstructive pulmonary disease an analysis from the Hokkaido COPD cohort study","volume":"194","author":"Suzuki","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2019.12.015_bib0320","doi-asserted-by":"crossref","first-page":"1702177","DOI":"10.1183\/13993003.02177-2017","article-title":"Eosinophils in COPD: how many swallows make a summer?","volume":"51","author":"Hamad","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2019.12.015_bib0325","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/15412555.2017.1386644","article-title":"Emphysematous phenotype is characterized by low blood eosinophils: a cross-sectional study","volume":"14","author":"Papaioannou","year":"2017","journal-title":"COPD"},{"key":"10.1016\/j.arbres.2019.12.015_bib0330","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2147\/COPD.S100338","article-title":"Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD","volume":"11","author":"Negewo","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2019.12.015_bib0335","doi-asserted-by":"crossref","first-page":"1800427","DOI":"10.1183\/13993003.00427-2018","article-title":"The reproducibility of COPD blood eosinophil counts","volume":"52","author":"Southworth","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2019.12.015_bib0340","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2147\/COPD.S165909","article-title":"Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort","volume":"13","author":"Greulich","year":"2018","journal-title":"Int J Chron Obstruct Dis"},{"key":"10.1016\/j.arbres.2019.12.015_bib0345","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201701-0009LE","article-title":"Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts","volume":"195","author":"Oshagbemi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2019.12.015_bib0350","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.arbres.2017.11.015","article-title":"Medical care according to risk level and adaptation to Spanish COPD Guidelines (GesEPOC): The Epoconsul Study","volume":"54","author":"Calle Rubio","year":"2018","journal-title":"Arch Bronconeumol"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289619306234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289619306234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:51:38Z","timestamp":1778511098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289619306234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0300289619306234"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2019.12.015","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2019.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}